Lyra Therapeutics (480 Biomedical)
IPOOur focus is a new solution for chronic rhinosinusitis.
Watertown, United States · Founded 2015 · $59.5M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- lyratherapeutics.com
- Total Funding
- $59.5M
- Last Round
- $30.0M Series CJan 2020
- Rounds
- 3
About
Clinical-stage biotechnology company developing innovative therapies for localized treatment of chronic rhinosinusitis (CRS).
Summary
Lyra Therapeutics (480 Biomedical) is a Biotech company based in Watertown, United States, founded in 2015. It has raised $59.5M in total across 3 rounds, most recently a $30.0M Series C round in Jan 2020. Investors include Polaris Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.